If Health Is Wealth, Then Access Is Capital
Health Access as Capital Strategy
It’s entirely understandable why many people, even those actively working to make the economy work for everyone, have tuned out the ongoing healthcare debates. These debates typically focus on coverage expansions, budget trade-offs, and more recently, fraud claims. But data on people’s lived experiences—across income levels, political affiliations, family size, and geography—reveal a consistent threat: health shocks directly trigger debt spirals, credit erosion, and blocked access to housing, education, and employment. Health access functions as pre-market capital—not a safety net benefit or the result of a more equitable economy, but a foundational input that determines whether families can participate in wealth-building systems at all.
In a global economy experiencing an affordability moment, the inaccessibility of basic healthcare stands out as an obvious economic bottleneck in the US. Grossman’s Model of Health Demand first presented health as a form of durable capital: it determines the total productive time individuals can devote to education, work, and wealth-building. Healthcare has been included as a broader example of bandwidth tax faced by the most vulnerable and financial toxicity. Chronic non-adherence results in worse health and spiraling financial consequences: missed work, emergency care, and long-term debt.
Evidence has been stronger for the upstream impacts—the direct effect of policies to lower individual medical debt and improve credit scores. Increasingly, we see the downstream benefits of expanding comprehensive income and supporting labor-force attachment with targeted intervention.
Health Access as an Investment
Many of my collaborators are not health-focused investors—they care primarily about downstream impacts. For some, the discourse about premiums and costs stressing small business ecosystems has been incomplete. It highlights the risk of business owners being disincentivized from hiring full-time workers but undervalues the lost worker productivity from health-related absenteeism. For others who use narrative change as a tool, clear language issues become important obstacles—perception of care depends on whether it’s called ACA or Obamacare.
But across the board for impact-minded investors, there’s a more central question:
How can we quantify the economic multiplier effects of preventing health shocks?
When reframed through the lens of capital recovery and growth, each health program becomes a targeted opportunity to expand financial stability, workforce resilience, and economic mobility.
The Health–Capital Flow Cycle below, modeled by previous researchers, helps identify strategic points of intervention and maps the inverse path to recovery and resilience:
For leaders considering health-related investments to support a more inclusive economy, this cycle provides a strategic investment map. The feedback loops embedded in this system suggest ideal entry points depending on your role:
Impact Investors → Target the Reinforcing Access Loop
When patients consistently access care, they stay healthier and employed. This generates higher productivity and consumer spending while reducing downstream health costs. It sparks a cycle of dollars being reallocated from emergency care to preventive services.
Programs like SIRUM demonstrate this flywheel effect. SIRUM redirects a significant portion of the billions of dollars in unused medications wasted annually into distributed capital—donated prescriptions that yield ~$150/month in savings per patient. Their custom logistics platform connects donors with safety-net clinics. In states like Ohio, their advocacy helped legalize donations from individuals—not just institutions—unlocking a grassroots supply of safe, unopened medications. This creates scale potential.
Impact investors can help similar innovators refine their models and prove scalability, eventually attracting broader funding from health systems or payers. Think of it as analogous to investing in renewable energy infrastructure during the early days of solar—here we’re investing in the infrastructure of a medication circular economy. The fuel is medicine, the output is health equity, and the return is both social and fiscal.
Philanthropy → Strengthen the Capacity Balancing Loop
Preventative care and better medication adherence means fewer ER visits—savings that flow to patients, employers, and insurers. But for systems to shift from reactive to preventive care, they need support to recalibrate revenue models. Here, philanthropy can do what markets will not: absorb risk to unlock scale.
Foundations should focus on enabling ecosystem health:
Support public-interest tech platforms that facilitate surplus medicine donations and underwrite program-related investments that provide early capital to social enterprises.
Fund state-level policy change, as seen in Indiana, California, and Tennessee. Fill advocacy gaps to standardize regulations and fund public education.
Regional and City Leaders → Enable the Capital Accumulation Loop
Stable health preserves financial capacity. When families avoid medical debt, they maintain credit, qualify for better housing and employment, and build resilience. Over time, this compounds into upward mobility.
Local leaders can:
Pass city or county resolutions urging hospitals and long-term care facilities to join donation programs.
Create localized Good Samaritan protections that encourage participation without fear of liability.
Most importantly, regional leaders should frame health as a workforce and mobility issue. Avoiding a $9,000 hospital bill can mean staying in stable housing, keeping a job, or having funds to start a business.
In this framework, health becomes capital—and capital can be cultivated, protected, and multiplied. People aren’t waiting for minor fixes to a broken system. We can invest strategically in the intervention points that already exist and expand access in ways that directly benefit communities.